Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants - Wikidata - wikimedia - TriplyDB

Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants

Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants

http://www.wikidata.org/entity/Q24624194

about

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)Second malignant neoplasms and cardiovascular disease following radiotherapy.Oral premalignancy: the roles of early detection and chemoprevention Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer Testicular cancer survivorship: research strategies and recommendations.Genetic variants in TGF-β pathway are associated with ovarian cancer risk.Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.A review of cancer risk prediction models with genetic variants.A genome-wide association study of self-rated health.Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.An unusual presentation of clear cell odontogenic carcinoma in mandibular anterior region.Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.Emerging molecular technologies for identifying the risk of second cancers.Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers Genetic variations in apoptosis pathway and the risk of ovarian cancer.Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer Family history of cancer and head and neck cancer survival.Implication of stem cells in the biology and therapy of head and neck cancer Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States.

P2860

Q24629078-F1346D59-AAB5-49F3-90FD-BBFB75A687C8 Q26796487-8BBF3F9E-1DF5-4638-AAEC-D5C4567AA5FD Q26864522-C4B849D0-DC05-452E-BA28-2B5C27AAE6C7 Q27693327-5FAA87E8-1AE1-41D0-936A-EE93C6CA1E58 Q33615319-A107FC5B-6318-4A68-A1FC-1F325721BEF8 Q33903227-401728CB-6289-4831-9EBC-4351B8C43306 Q33940693-545D9863-3BD0-4AAC-ACF9-281F8CD39E28 Q34039684-B75608D1-887C-417C-8C0E-51BDA8ED6E68 Q34044950-7DDD715F-B3A0-4CE5-B36B-9777049670BB Q34180253-40652FBC-EB2D-4DC0-9108-FC72F433D4C8 Q34265269-89332ED5-93AB-446D-BC0F-3A0C3094F23C Q34585466-820DE5AA-BF44-4EB9-8C6A-1AAA9176B153 Q34682926-6ED50015-76BD-4B65-8723-9CD62BADECEE Q34683811-8CF86A52-C2B0-499C-8C9B-6E266A5A3ADD Q35228293-DEF8E726-F529-4A9D-B240-8AB3C1148F4C Q35536085-9F2FF8E3-0D2A-41BD-9C3B-4224FFE4A78C Q35562928-6C37E529-6599-4336-8065-EB54E390574D Q35842157-9FBEB2A8-B480-45DA-9980-75A4D246490E Q35917835-6B48127B-69BE-4100-B7DB-C0B760C257FE Q35962631-2A845041-16B3-4073-AAC7-2BB07E0FA9A8 Q36070191-94D39900-D41D-4085-8557-C6D85797CEF4 Q36115675-B753A22E-FF3F-42E7-8DAA-930BD36EC6C7 Q36638191-B389823D-029B-46CC-B311-E4944AB1D3BC Q36680283-7BAAE889-35C4-4FE9-A802-031F067ED48D Q36698880-5E532C3F-883C-4120-BE4D-6451CC95D18A Q36908209-868A4592-31E5-4D7B-856F-0E25500619A6 Q36971948-2DFD3967-DBD0-4973-B403-17D04F61F91A Q37322288-6DA44F28-7DA7-4551-9F78-7854434E79E4 Q37595614-A3491A72-644D-486D-AA59-71FC17B4566D Q37636693-D988381D-9D5A-4AD0-9C2C-D3DD09E343CA Q37638788-97633195-B42D-44E2-8605-F0A0865FD014 Q37662864-0E2C31B2-E739-4155-9AF9-49C3F7BE3EE1 Q37730044-F97A8689-320C-492A-86CD-B9BDDB99CAB6 Q37731815-72BAD9B7-88C5-45C1-A530-329B5B65C625 Q40305507-49DA34D6-1E65-4250-869C-C9AD65C6D269 Q42143399-15CD0C7C-49F8-43F3-B34E-B0D1FF3E41B1 Q45837886-1C9A1FEE-C0A4-4A0D-B97C-061AF36A5632

P2860

Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants

http://www.wikidata.org/entity/Q24624194

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Novel susceptibility loci for ...... evaluation of genetic variants

@ast

Novel susceptibility loci for ...... evaluation of genetic variants

@en

Novel susceptibility loci for ...... evaluation of genetic variants

@nl

type

label

Novel susceptibility loci for ...... evaluation of genetic variants

@ast

Novel susceptibility loci for ...... evaluation of genetic variants

@en

Novel susceptibility loci for ...... evaluation of genetic variants

@nl

prefLabel

Novel susceptibility loci for ...... evaluation of genetic variants

@ast

Novel susceptibility loci for ...... evaluation of genetic variants

@en

Novel susceptibility loci for ...... evaluation of genetic variants

@nl

P1433

Q24624194-37DC7408-CB74-4A91-8ACB-0E0346F86121

P1476

Q24624194-F9D95F22-4B1B-425B-9FAC-A25793AC7500

P2093

Q24624194-03336A31-9BF4-4F98-8F29-F6B924E52998

Q24624194-3C240CDA-368D-4228-BE30-A869284CC450

Q24624194-57BB2921-7E0E-4B7C-B9C3-CD6F8712340A

Q24624194-66705D08-B0CB-400A-AD0A-1B68D3BA0A46

Q24624194-7253618D-F0A6-4DAD-B6D5-9A303634DE82

Q24624194-79CD33C7-0C2C-4602-BD70-C774365AC468

Q24624194-9524E459-E22E-4830-9676-6BBD841151F6

Q24624194-953B940F-85DA-4AE1-ABD5-154F47826A72

Q24624194-C07D84D4-A414-4B28-8FB8-165DA879B86E

Q24624194-F2DCC112-E079-42B7-83F1-5A56D62B59CE

P2860

Q24624194-0EC57EA5-891B-4FE7-ADE0-B1ED7A185D67

Q24624194-141CDDB3-9D08-4B36-9197-3E91846E0592

Q24624194-149EFAB0-057D-45F2-A5F7-1A5CF7AB0ECC

Q24624194-23889809-4D28-4FF0-A356-CBF664A56328

Q24624194-3933BDB1-F3A4-4A3D-9968-8DEB3B862F6A

Q24624194-394E998A-7FBB-4AE6-9360-CE550B4ED74F

Q24624194-3FCB6A5A-E49A-4513-A1D4-A0D098861849

Q24624194-48200CAE-5D82-45C9-B7BB-048669636F95

Q24624194-5D4E313A-0D36-498F-A7B7-4D081E30C3DC

Q24624194-68CE5F9A-A470-441A-A794-F045B5D54294

P304

Q24624194-67FEAEE0-2B0F-442C-81CD-C404E0E30CEB

P31

Q24624194-03F060FD-E57E-4D5B-8BA5-BFE48DCAB633

P3181

Q24624194-8C80B763-7726-4F94-A5B5-0BD81D1C1EF4

P356

Q24624194-7D62CF9B-36BF-4E2F-89CB-A697A03EA0F8

P407

Q24624194-138E8884-FBCD-483D-A6A4-03607F887ECC

P433

Q24624194-DEC20645-66B6-47CB-85D5-917701BF8709

P478

Q24624194-0B1EA86A-6B44-4ABA-9EDD-DF2F053B3EDD

P50

Q24624194-E26682B0-936A-4A73-94FC-1633E3C25E66

P577

Q24624194-64142283-0422-4D6D-809C-5EB735C5E105

P698

Q24624194-42709A06-FDEE-46EB-B074-7689FA860CD2

P921

Q24624194-D235FDDD-363B-427E-B90F-87F111F66B12

P932

Q24624194-9D50467F-2C5A-40A5-858D-5C1CBE7222D3

P3181

P356

1940-6207.CAPR-09-0025

P1433

Cancer Prevention Research

P1476

Novel susceptibility loci for ...... evaluation of genetic variants

@en

P2093

Edward Kim

http://www.w3.org/2001/XMLSchema#string

Fadlo R Khuri

http://www.w3.org/2001/XMLSchema#string

Hushan Yang

http://www.w3.org/2001/XMLSchema#string

J Jack Lee

http://www.w3.org/2001/XMLSchema#string

Jian Gu

http://www.w3.org/2001/XMLSchema#string

Margaret R Spitz

http://www.w3.org/2001/XMLSchema#string

Scott M Lippman

http://www.w3.org/2001/XMLSchema#string

Waun K Hong

http://www.w3.org/2001/XMLSchema#string

Xifeng Wu

http://www.w3.org/2001/XMLSchema#string

Yuanqing Ye

http://www.w3.org/2001/XMLSchema#string

P2860

XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining

Statistical significance for genomewide studies

Mitochondrial defects in cancer

On the Origin of Cancer Cells

Facile detection of mitochondrial DNA mutations in tumors and bodily fluids

Rare loss-of-function mutation of a death receptor gene in head and neck cancer

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

A network-based analysis of systemic inflammation in humans

VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.

P304

617-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4437099

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1940-6207.CAPR-09-0025

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19584075

http://www.w3.org/2001/XMLSchema#string

P921

susceptibility locus

P932

2964280

http://www.w3.org/2001/XMLSchema#string